Contraception

Reproductive·MeSH: Contraception Behavior

8 drugs in development·4 companies·12 clinical trials

Drug Pipeline by Phase

Approved(1)

Drug	Company
twirla	AGILE THERAPEUTICS INC (AGRX)

Phase 3(3)

Drug	Company
low dose estrogen weekly dermal	Viatris Inc (VTRS)
NOMAC-E2 COC	Organon & Co. (OGN)
twirla	Corium International, Inc. (CORI)

Phase 2(1)

Drug	Company
etonogestrel-releasing ius	Organon & Co. (OGN)

Preclinical(3)

BioSniper tracks 8 drugs in development for Contraception across 4 companies.

There are 12 clinical trials targeting Contraception tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.